Package Leaflet: Information for the User
Coaguban 10 mg film-coated tablets EFG
Rivaroxaban
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the package leaflet:
Coaguban contains the active substance rivaroxaban and is used in adults to:
Rivaroxaban belongs to a group of medications called antithrombotic agents. It works by blocking a clotting factor (factor Xa) and thus reducing the tendency of blood to form clots.
Do not take Coaguban
Do not take Coaguban and inform your doctorif any of these circumstances apply to you.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Rivaroxaban
Be careful with Coaguban
Inform your doctor if you have any of these situationsbefore taking rivaroxaban. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If you need surgery
It is very important to take rivaroxaban exactly at the times indicated by your doctor.
Inform your doctor immediately if you experience numbness or weakness in your legs or problems in your intestines or bladder at the end of anesthesia, as urgent attention is necessary.
Children and adolescents
Rivaroxaban is not recommended for children under 18 years of age.There is not enough information about its use in children and adolescents.
Other medications and Coaguban
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication, including those purchased without a prescription.
If you are taking:
If any of the above circumstances apply to you, inform your doctorbefore taking Coaguban, as the effect of rivaroxaban may be increased. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing stomach or intestinal ulcers, they will recommend that you also use a preventive treatment for ulcers.
If you are taking:
If any of the above circumstances apply to you, inform your doctorbefore taking Coaguban, as the effect of rivaroxaban may be decreased. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
Pregnancy and breastfeeding
Do not take Coaguban if you are pregnant or breastfeeding. If there is any possibility that you may become pregnant, use a reliable contraceptive while taking this medication. If you become pregnant while taking this medication, inform your doctor immediately, who will decide how you should be treated.
Driving and using machines
Coaguban may cause dizziness (frequent side effect) or fainting (uncommon side effect) (see section 4, "Possible side effects"). You should not drive or use machines if you are affected by these symptoms.
Coaguban contains lactose.
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Coaguban contains sodium.
This medication contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially "sodium-free"
Follow your doctor's instructions for taking this medication exactly. If you are unsure, consult your doctor or pharmacist again.
What dose to take
To prevent the formation of blood clots in the veins after hip or knee replacement surgery.
The recommended dose is one 10 mg rivaroxaban tablet once a day.
To treat blood clots in the veins of the legs and in the blood vessels of the lungs, and to prevent blood clots from recurring.
After at least 6 months of treatment for blood clots, the recommended dose is one 10 mg tablet once a day or one 20 mg tablet once a day. Your doctor has prescribed rivaroxaban 10 mg once a day for you.
You should take Rivaroxaban with food. Swallow the tablets, preferably with water. If you have difficulty swallowing the tablet whole, consult your doctor about other ways to take rivaroxaban. The tablet can be crushed and mixed with water or apple puree, immediately before taking it.
If necessary, your doctor may also administer the crushed rivaroxaban tablet through a gastric tube.
When to take Coaguban
Take one tablet every day, until your doctor tells you to stop.
Try to take one tablet at the same time every day, to help you remember.
Your doctor will decide how long you should continue taking the treatment.
To prevent the formation of blood clots in the veins after hip or knee replacement surgery:
Take the first tablet between 6 and 10 hours after surgery.
If you have undergone major hip surgery, you will usually take tablets for 5 weeks.
If you have undergone major knee surgery, you will usually take tablets for 2 weeks.
If you take more Coaguban than you should
Call your doctor immediately if you have taken too many rivaroxaban tablets. Taking too much medication increases the risk of bleeding. In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Coaguban
If you forget to take a dose, take it as soon as you remember. Take the next tablet the next day and, after that, take one tablet every day, as usual. Do not take a double dose to make up for forgotten doses.
If you stop taking Coaguban
Do not stop taking rivaroxaban without talking to your doctor first, as this medication prevents the development of a serious condition.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Like other similar medications (antithrombotics), Coaguban may cause bleeding that can be life-threatening. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be apparent.
Possible side effects that may be signs of bleeding:
Tell your doctor immediatelyif you experience any of the following symptoms:
Your doctor will decide whether to keep you under closer observation or change your treatment.
Possible side effects that may be signs of a severe skin reaction
Tell your doctor immediatelyif you experience skin reactions such as:
Possible side effects that may be signs of a severe allergic reaction
Tell your doctor immediatelyif you experience any of the following side effects:
General list of possible side effects
Common(may affect up to 1 in 10 patients):
Uncommon(may affect up to 1 in 100 patients):
Rare(may affect up to 1 in 1,000 patients):
Frequency not known(frequency cannot be estimated from available data):
Reporting side effects
If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: www.notificaRAM.es
By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date shown on the packaging and on each blister, after "CAD" or "EXP". The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in your pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Coaguban
Tablet core: microcrystalline cellulose, sodium croscarmellose, lactose monohydrate, sodium lauryl sulfate, magnesium stearate, and hydroxypropyl methylcellulose.
Tablet film coating: macrogol 3350, hypromellose, titanium dioxide (E-171), red iron oxide (E-172).
Appearance of the Product and Package Contents
Coaguban 10 mg film-coated tablets are round, biconvex, pink, engraved with "E2" on one side and smooth on the other side.
They are packaged in PVC-PVdC/Aluminum blisters, in packs of 10 and 30 film-coated tablets, or in precut unit-dose blisters in packs of 100 x 1.
They are also available in HDPE bottles, in packs of 30 film-coated tablets.
Marketing Authorization Holder
Towa Pharmaceutical Europe, S.L.
C/ de Sant Martí, 75-97
08107 Martorelles, Barcelona, Spain
Manufacturer
Towa Pharmaceutical Europe, S.L.
C/de Sant Martí, 75-97, 08107, Martorelles, Barcelona, Spain.
Pharmadox Healthcare Ltd.
KW20A Kordin Industrial Park, PLA3000, Paola, Malta
Date of the Last Revision of this Leaflet:October 2024
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://aemps.gob.es/